Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 05/06 10:00:01 pm
73.13 USD   +0.25%
01:41a EXPRESS SCRIPTS : Transplant recipient has trouble with prescription..
01:09a Goldberg Law PC Announces an Investigation of Claims against Expr..
05/05 Rosen Law Firm Announces Filing of Securities Class Action Lawsui..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales104 099100 887101 752102 292104 214107 107
Operating income (EBITDA)6 6646 8037 0477 2957 4397 555
Operating profit (EBIT)6 2956 4336 6476 3616 2806 532
Pre-Tax Profit (EBT)3 030-----
Net income1 8452 0082 4762 9533 0763 264
P/E ratio31,232,124,615,314,112,4
EPS ( $ )2,252,643,564,785,185,88
Dividend per Share ( $ )------
Yield------
Reference price ( $ )70.2484.6787.4172.9572.9572.95
Announcement Date02/20/2014
09:48pm
02/23/2015
09:01pm
02/16/2016
09:09pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt11 95611 73512 40612 53510 7508 701
Finance------
Operating income (EBITDA)6 6646 8037 0477 2957 4397 555
Leverage
(Debt/EBITDA)
1,79x1,73x1,76x1,72x1,45x1,15x
Capital Expenditure423437296327380392
Book Value Per Share (BVPS)28,2 $27,6 $25,7 $25,5 $26,4 $27,7 $
Cash Flow per Share5,80 $5,99 $6,97 $8,47 $9,70 $11,2 $
Announcement Date02/20/2014
09:48pm
02/23/2015
09:01pm
02/16/2016
09:09pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 46 144 M$ -
Entreprise Value (EV) 58 678 M$ 56 894 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 15,3x 14,1x
Capitalization / Revenue 0,45x 0,44x
EV / Revenue 0,57x 0,55x
EV / EBITDA 8,04x 7,65x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,86x 2,77x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 6,22% 6,03%
operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) 2,89% 2,95%
ROA (Net Profit / Asset) 6,78% 7,13%
ROE (Net Profit / Equities) 21,8% 23,4%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   0,32% 0,36%
Cash Flow / Sales 5,24% 5,88%
Capital Intensity (Assets / Sales) 0,43x 0,41x
Financial Leverage (Net Debt / EBITDA) 1,72x 1,45x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend